HMPV (Human Metapneumovirus): The Silent Threat to Respiratory Health
Bioeksen R&D Technologies
Bio-Speedy? , Molecular Diagnostic, R&D , Biotechnology
What is HMPV? Prevalence and Epidemiology
Human metapneumovirus (HMPV) is a significant respiratory pathogen that primarily infects children, the elderly, and individuals with weakened immune systems. HMPV belongs to the Paramyxoviridae family and is closely related to respiratory syncytial virus (RSV) (Williams JV et al., 2004).
Globally, HMPV accounts for approximately 5-15% of respiratory tract infections, with higher prevalence in late winter and early spring. Seasonal epidemics of HMPV are driven by its high transmissibility, with healthcare settings often experiencing an influx of cases during peak periods (Panda S et al., 2014). Despite its widespread prevalence, HMPV is often underdiagnosed due to overlapping symptoms with other respiratory viruses.
HPMV Symptoms and Transmission?
Human metapneumovirus (HMPV) primarily infects the respiratory epithelium, leading to various respiratory symptoms which is fever cough, nasal congestion, shortness of breath, and wheezing (van den Hoogen BG et al., 2001 & (Williams JV et al., 2004)). The virus spreads easily through close contact with an infected individual, as well as via respiratory droplets expelled during coughing or sneezing. Additionally, touching contaminated surfaces (Boivin G. et al., 2003). The incubation period of HMPV is typically 3-5 days, after which symptoms begin to manifest (Hamelin ME. et al., 2005).
While most cases result in mild upper respiratory symptoms, the virus can cause severe lower respiratory tract conditions, such as bronchiolitis or pneumonia, especially in young children, the elderly, and immunocompromised individuals (Falsey et al., 2003 & Esper F. et al., 2004). This broad range of symptoms highlights the importance of early detection and preventive measures to reduce its impact on vulnerable populations (Schildgen O. et al., 2011).
HMPV Diagnosis and Solutions: How is it Detected?
The diagnosis of human metapneumovirus (HMPV) relies on advanced laboratory techniques due to the nonspecific nature of its clinical symptoms. Molecular methods, particularly reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR (qPCR), are considered the gold standard for detecting HMPV RNA in respiratory specimens (Maertzdorf J. et al., 2004). These techniques are highly sensitive and specific, enabling accurate identification of the virus even at low viral loads (Boivin G. et al., 2002).
The Biospeedy Human Metapneumovirus Detection RT-qPCR Kit leverages these advanced technologies, providing rapid and precise results through reverse transcription and real-time PCR (RT-qPCR). By integrating molecular diagnostic solutions such as this, laboratories can ensure quick and reliable detection of HMPV, saving valuable time for healthcare professionals and supporting effective infection control measures.
领英推荐
References:
1.?????? Boivin G, Abed Y, Pelletier G, et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory tract infections in all age groups. Journal of Clinical Microbiology. 2002;40(9):3860-3863. doi:10.1128/JCM.40.9.3860-3863.2002
2.?????? Boivin G, De Serres G, Hamelin ME, et al. Human metapneumovirus infections in hospitalized children: a 6-year study. Pediatrics. 2003;112(6):e467. doi:10.1542/peds.112.6.e467
3.?????? Esper F, Martinello RA, Boucher D, et al. A 1-year experience with human metapneumovirus in children aged <5 years. Journal of Infectious Diseases. 2004;189(8):1388-1396. doi:10.1086/382482
4.?????? Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. Journal of Infectious Diseases. 2003;187(5):785-790. doi:10.1086/368163
5.?????? Maertzdorf J, Wang CK, Brown JB, et al. Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. Journal of Clinical Microbiology. 2004;42(3):981-986. doi:10.1128/JCM.42.3.981-986.2004
6.?????? Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: Review of an important respiratory pathogen. International Journal of Infectious Diseases. 2014;25:45-52. doi:10.1016/j.ijid.2014.03.1391
7.?????? Schildgen O, Müller A, Allander T, et al. Human metapneumovirus: lessons learned over the first decade. Clinical Microbiology Reviews. 2011;24(4):734-754. doi:10.1128/CMR.00015-11
8.?????? Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. New England Journal of Medicine. 2004;350(5):443-450. doi:10.1056/NEJMoa025472
9.?????? Van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nature Medicine. 2001;7(6):719-724. doi:10.1038/89098
A creative copywriter, compelling storyteller and social media enthusiast. ?? Senior Content Writer at Borderless Access PVT. LTD. ??Bengaluru
1 个月HMPV, not as serious as Covid-19? Find out: https://mdforlives.com/blog/surge-in-human-metapneumovirus/